You watched
Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
2
Wishlist
0
Compare
0
Contacts

Strophantin-G solution for injection 0.025% ampoule 1 ml in blister No. 10

SKU: an-4621
0
All about product
Description
Specification
Reviews 0
Questions0
new
Strophantin-G solution for injection 0.025% ampoule 1 ml in blister No. 10
In Stock
102.60 грн.
Buy this product in 1 click:
Active ingredient:Strophantine
ATC code:C MEDICINES AFFECTING THE CARDIOVASCULAR SYSTEM; C01 CARDIOLOGICAL DRUGS; C01A CARDIAC GLYCOSIDES; C01A C Strophanthine glycosides; C01A C01 G-strophanthin
Country of manufacture:Ukraine
Dosage:0.25 mg/ml
Form:Ampoules
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Strophantin-G solution for injection 0.025% ampoule 1 ml in blister No. 10
102.60 грн.
Description

Pharmacological properties

A cardiac glycoside that has a positive effect, as well as a negative chrono- and dromotropic effect.

In heart failure, it increases stroke volume and cardiac output, improves ventricular emptying, which leads to a decrease in heart size and a decrease in myocardial oxygen demand.

The effect of the drug appears 2-10 minutes after saturation is reached. The duration of action of Strophantin-G is from 1 to 3 days.

Indication

Acute cardiovascular failure, chronic heart failure stage III-IV according to NYHA, supraventricular tachycardia, atrial fibrillation.

Application

In / in slowly. Maximum single dose - 0.25 mg, daily - 1 mg. The drug is administered in low doses of 0.1-0.15 mg with an interval of 30 minutes to 2 hours. At an average rate of digitalization during the saturation period, 0.25 mg is usually administered 2 times a day with an interval of 12 hours. The duration of the saturation period is on average 2 days. The maintenance dose of strophanthin-g, as a rule, does not exceed 0.25 mg/day.

Contraindication

Glycoside intoxication, ventricular tachycardia, AV block II and III degree, severe bradycardia, hypercalcemia, hypokalemia, isolated mitral stenosis, hypertrophic obstructive cardiomyopathy, carotid sinus syndrome, thoracic aortic aneurysm, WPW S-M, acute myocardial infarction.

Side effects

Allergic reactions are possible (rarely). Other side effects of strophanthin-g are mainly due to its overdose or the patient's hypersensitivity to cardiac glycosides.

Interactions

The simultaneous use of strophanthin-g with sympathomimetics, methylxanthines, reserpine and tricyclic antidepressants increases the risk of developing arrhythmia.

The concentration of Strophanthin-G in blood plasma increases with the simultaneous administration of quinidine, amiodarone, and captopril.

Diuretics, corticosteroids, insulin, and calcium supplements increase the risk of glycoside intoxication.

Overdose

Symptoms of overdose of strophanthin-g (glycoside intoxication) are diverse. From the cardiovascular system: arrhythmias, including bradycardia, AV block, ventricular tachycardia or extrasystole, ventricular fibrillation. From the digestive tract: anorexia, nausea, vomiting, diarrhea. From the central nervous system and sensory organs: headache, increased fatigue, dizziness, rarely - coloring of surrounding objects in green and yellow, flickering of flies before the eyes, decreased visual acuity, scotoma, macro- and micropsia; very rarely - confusion, syncope. If glycoside intoxication develops, the drug should be canceled; prescribe potassium preparations, parenteral administration of unitiol, symptomatic therapy.

Storage conditions

In a place protected from light.

Specifications
Characteristics
Active ingredient
Strophantine
ATC code
C MEDICINES AFFECTING THE CARDIOVASCULAR SYSTEM; C01 CARDIOLOGICAL DRUGS; C01A CARDIAC GLYCOSIDES; C01A C Strophanthine glycosides; C01A C01 G-strophanthin
Country of manufacture
Ukraine
Dosage
0.25 mg/ml
Form
Ampoules
Method of application
Injections
Primary packaging
ampoule
Producer
DZ DNTSLZ LLC
Quantity per package
10 ampoules
Trade name
Strophantine
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Ramizes Com tablets 5 mg + 25 mg blister No. 30
In stock
0
442.29 грн.
102.60 грн.